Preoperative Drug Monitoring in Management of Patients with Hip Fracture on Treatment with Direct Oral Anticoagulants.
Carlo RostagnoGiulio Maria MannarinoAlessandro CarteiGaia RubbieriAlice CeccofiglioAnna Maria GoriRoberto CivininiRossella MarcucciPublished in: Clinical interventions in aging (2024)
DOAC assay in patients with hip fracture may be useful for correct definition of time to surgery, particularly in patients who are candidates for neuraxial anesthesia. Two-thirds of patients with DOAC levels <50 ng/mL at 48 hours from last drug intake underwent uneventful neuraxial anesthesia, saving at least 24 hours in comparison to guidelines.
Keyphrases
- hip fracture
- direct oral anticoagulants
- venous thromboembolism
- atrial fibrillation
- end stage renal disease
- newly diagnosed
- minimally invasive
- patients undergoing
- high throughput
- coronary artery bypass
- prognostic factors
- coronary artery disease
- patient reported outcomes
- emergency department
- acute coronary syndrome
- combination therapy
- physical activity
- body mass index